Clinical trial
Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent…
NCT00277654 · Lindner Center of HOPE, Other · Completed
Key facts
| NCT number | NCT00277654 |
|---|---|
| Title | Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder |
| Lead sponsor | Lindner Center of HOPE, Other |
| Collaborators | Janssen Pharmaceuticals Industry University of Cincinnati |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bipolar Disorder, Anxiety Disorder |
| Intervention type | Drug |
| Interventions | Risperidone |
| Enrollment | 111 |
| Start date | Feb 1, 2004 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Jan 16, 2006 |
| Last update posted | Dec 13, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: